In the current study, we provide the first integrated analysis of gene expression, DNA methylation and genetic variation of the IGF2/H19 locus in adrenal tumor subtypes using high-resolution molecular technologies to unravel the driving force behind IGF2 overexpression in these tumors. This evidence concerns the gene IGF2 and adrenal gland neoplasm.